Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Study Phase
Phase 2BPhase 3
Study Completion Date
November 2012
NCT01124786Uploaded 10-02-2020
Available for Download
PDS UID: Pancrea_Multipl_2020_430
A Phase II Randomized, Open-Label, Multicenter Study Comparing CO-1.01 With Gemcitabine as First-Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma
PROTOCOLLinked Pancrea_ClovisO_2010_186 Documentation.docx
CRFDataset Contents and Variable Crosswalk.xlsx
DATA DICTIONARYCODEBOOK_linked_pancrea186.pdf
DATA SUMMARYDescriptive_Stats_Linked_Pancrea_ClovisO_2010_186.xlsx
DATA SUMMARYProc Contents Data Dictionary linked_pancrea186.pdf
DATA (COMPARATOR ARM)linked_pancrea186.sas7bdat